Heath K E, Day I N, Humphries S E
Centre for Cardiovascular Genetics, The Rayne Institute, University College Medical School, 5 University Street, London WC1E 6JJ, UK.
J Med Genet. 2000 Apr;37(4):272-80. doi: 10.1136/jmg.37.4.272.
A method based on quantitative fluorescent multiplex PCR has been developed to detect major rearrangements of the low density lipoprotein receptor gene (LDLR) which account for approximately 5% of mutations. The method involves two PCR reactions; the first (P1) amplifies the selected exons using unique primer sequences tagged with newly designed universal primers, while the second (P2) amplifies the P1 amplicons using the universal primers. One of the P2 universal primers is labelled with a fluorescent dye which is incorporated into the PCR products which are then electrophoresed on an ABI DNA sequencer. The relative amounts of the amplified peak areas are determined and compared to ratios obtained for DNA from four normal controls and known major rearrangements. The multiplex set developed is based on LDLR exons 3, 5, 8, 14, and 17 and 86% of reported major rearrangements would be detectable by this assay as well as any deletions and insertions of greater than 1 bp. The method was evaluated using DNA from 15 reported deletions and duplications which were all correctly identified. Two groups of UK patients with a clinical diagnosis of familial hypercholesterolaemia (FH) and where no mutation had been identified in LDLR or APOB (14 children and 42 adults) were screened for the presence of major LDLR rearrangements by this assay. Three major rearrangements were detected and a 4 bp duplication was identified in a fourth patient. Since it avoids the problems associated with Southern blotting, this method will be useful for detecting gene rearrangements.
一种基于定量荧光多重PCR的方法已被开发出来,用于检测低密度脂蛋白受体基因(LDLR)的主要重排,这些重排约占突变的5%。该方法涉及两个PCR反应;第一个反应(P1)使用带有新设计通用引物的独特引物序列扩增选定的外显子,而第二个反应(P2)使用通用引物扩增P1扩增子。P2通用引物之一用荧光染料标记,该染料掺入PCR产物中,然后在ABI DNA测序仪上进行电泳。确定扩增峰面积的相对量,并与从四个正常对照和已知主要重排的DNA获得的比率进行比较。所开发的多重检测组基于LDLR外显子3、5、8、14和17,该检测可检测86%报告的主要重排以及任何大于1 bp的缺失和插入。使用来自15个报告的缺失和重复的DNA对该方法进行评估,所有这些均被正确识别。通过该检测对两组临床诊断为家族性高胆固醇血症(FH)且在LDLR或APOB中未发现突变的英国患者(14名儿童和42名成人)进行主要LDLR重排的筛查。检测到三个主要重排,并在第四名患者中鉴定出一个4 bp的重复。由于它避免了与Southern印迹相关的问题,该方法将有助于检测基因重排。